Not all patients with CLL have to have therapy. Despite all the latest advancements, the iwCLL nevertheless endorses watchful observation for sufferers with asymptomatic illness.86 This suggestion relies on at the least two randomized trials evaluating observation to possibly chlorambucil monotherapy or fludarabine, cyclophosphamide and rituximab (